Eirgen Pharma Ltd.
Records under this name other than the patents Eirgen Pharma Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 42 patents it holds.
Showing 1 to 8 of 8 · Back to Eirgen Pharma Ltd.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,745,671 | Method for producing scyllo-inositol Term ended Term ended May 1, 2026 · From the USPTO record | Term ended | Term ended May 1, 2026 | From the USPTO record |
| US 9,913,852 | Method of Treating and Preventing Secondary Hyperparathyroidism Lapsed on the fee record Ended Mar 13, 2026 · High confidence | Lapsed on the fee record | Ended Mar 13, 2026 | High confidence |
| US 9,907,816 | Water-Insoluble, Iron-Containing Mixed Metal, Granular Material Lapsed on the fee record Ended Mar 6, 2026 · High confidence | Lapsed on the fee record | Ended Mar 6, 2026 | High confidence |
| US 7,427,670 | Cytochrome P450 24 (CYP24) Monoclonal Antibody and Methods and Uses Thereof Term ended Term ended Feb 28, 2026 · High confidence | Term ended | Term ended Feb 28, 2026 | High confidence |
| US 8,409,833 | Method for producing scyllo-inositol Term ended Term ended Dec 4, 2025 · From the USPTO record | Term ended | Term ended Dec 4, 2025 | From the USPTO record |
| US 8,574,862 | Methods and Composition for Measuring the Amount of Vitamin D Derivatives Lapsed on the fee record Ended Nov 5, 2025 · High confidence | Lapsed on the fee record | Ended Nov 5, 2025 | High confidence |
| US 8,715,974 | Method for producing scyllo-inositol Term ended Term ended Oct 14, 2024 · From the USPTO record | Term ended | Term ended Oct 14, 2024 | From the USPTO record |
| US 7,288,407 | Stable Cytochrome P450 24 (CYP24) Expressing Cell Line and Methods and Uses Thereof Term ended Term ended May 2, 2023 · High confidence | Term ended | Term ended May 2, 2023 | High confidence |